Alliance Global Partners Initiates Coverage On Vaccitech with Buy Rating, Announces Price Target of $12
Portfolio Pulse from Benzinga Newsdesk
Alliance Global Partners analyst James Molloy has initiated coverage on Vaccitech (NASDAQ:VACC) with a Buy rating and a price target of $12.
September 25, 2023 | 1:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vaccitech has been given a Buy rating by Alliance Global Partners with a price target of $12.
The Buy rating and price target set by Alliance Global Partners is a positive signal for Vaccitech. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100